GERCOD

GERCOD (Groupe d'Étude et de Recherche Clinique en Oncologie et Radiothérapie) is a French clinical research organization and cooperative group specializing in oncology, with a primary focus on digestive and thoracic cancers. The organization functions as a sponsor and coordinator for multicenter clinical trials, facilitating the evaluation of innovative therapeutic strategies and pharmaceutical agents. GERCOD works in close collaboration with academic institutions, hospitals, and the pharmaceutical industry to advance cancer treatment through high-quality clinical data. Their expertise spans Phase I through Phase III trials, covering modalities such as targeted therapies, immunotherapies, and optimized chemotherapy regimens. By bridging the gap between academic research and clinical practice, GERCOD plays a vital role in establishing new standards of care for cancer patients in Europe.